polyoxometal
pom
interest
biomed
agent
due
versatil
anticanc
antivir
properti
remark
antihiv
activ
although
pom
tunabl
easili
access
inorgan
drug
prototyp
principl
full
potenti
tap
enhanc
biocompat
exampl
organ
function
therefor
investig
proteas
inhibit
potenti
function
kegginand
dawsontyp
pom
organ
side
chain
inhibitori
perform
furthermor
compar
pom
type
buffer
depend
result
discuss
addit
chemic
shift
map
nmr
experi
perform
exclud
pomsubstr
interact
wherea
introduct
organ
side
chain
pom
promis
approach
principl
influenc
secondari
effect
reaction
system
also
merit
detail
investig
polyoxometal
pom
transit
metal
oxid
cluster
prefer
form
w
mo
v
high
oxid
state
ever
grow
number
complex
structur
architectur
bring
forward
impress
applic
potenti
attract
widespread
research
attent
exampl
respect
key
technolog
applic
electro
catalyt
process
magnet
materi
nanotechnolog
anoth
special
featur
pom
versatil
bioactiv
lead
antibacteri
anticanc
antivir
properti
wide
review
past
year
pom
proven
activ
wide
rang
virus
includ
differ
influenza
strain
dengu
fever
viru
sar
coronaviru
furthermor
test
promis
antihiv
agent
sinc
full
outbreak
aid
epidem
first
breakthrough
report
first
vivo
studi
human
perform
nasb
w
polyanion
commonli
abbrevi
howev
caus
sever
side
effect
higher
dosag
forc
patient
discontinu
therapi
sinc
search
second
gener
antihiv
pom
reduc
toxic
continu
pti
w
polyanion
abbrevi
exampl
identifi
potenti
antivir
drug
capabl
inhibit
replic
herp
simplex
viru
hsv
despit
multitud
empir
investig
antivir
activ
pom
littl
known
interact
mechan
virus
cell
concern
antihiv
activ
inou
et
al
investig
inhibit
revers
transcriptas
rt
variou
pom
interestingli
cell
cultur
experi
show
activ
pom
consider
correl
rt
inhibit
followup
studi
group
identifi
kegginand
dawsonpom
type
possibl
lead
compound
antihiv
activ
novel
inhibit
mechan
proteas
dawsontyp
pom
propos
pioneer
studi
hill
et
al
high
activ
niobiumsubstitut
tungstat
p
w
nbo
explain
bind
flexibl
hing
region
surfac
proteas
organ
proteas
inhibitor
bind
activ
site
larger
inorgan
cluster
molecul
pom
would
thu
open
new
way
inhibit
altern
interact
pathway
pom
proteas
would
render
less
sensit
toward
frequent
occur
mutat
therebi
circumv
problem
therapeut
resist
current
aid
therapi
addit
antiaid
drug
costli
compound
administ
inconveni
high
dose
sever
time
day
pom
would
offer
econom
advantag
current
antiaid
drug
principl
easili
synthes
readili
avail
precursor
synthet
step
follow
year
wit
report
antivir
pom
new
insight
obtain
regard
interact
pom
humanbovin
serum
albumin
protein
kinas
nevertheless
fundament
issu
pom
toxic
still
remain
overcom
order
turn
power
versatil
lowcost
inorgan
antihiv
agent
howev
develop
hybrid
function
pom
proceed
rapidli
pom
biomacromolecular
matric
addit
strategi
increas
gap
grow
class
novel
pom
biomed
character
inspir
us
screen
select
varieti
pom
type
respect
inhibitori
effect
proteas
firstli
compar
inhibitori
potenti
pom
differ
cluster
size
focus
kegginand
dawsontyp
pom
differ
organ
side
chain
order
evalu
influenc
function
inhibitori
perform
addit
place
emphasi
methodolog
issu
result
critic
discuss
respect
consider
buffer
depend
furthermor
present
nmr
studi
solut
exclud
possibl
pomsubstr
interact
pom
synthes
accord
publish
procedur
summar
tabl
figur
illustr
structur
motif
kegginand
dawsontyp
major
investig
pom
organ
substitut
deriv
emerg
recent
develop
novel
function
approach
pom
includ
repres
sandwichtyp
lacunari
pom
build
block
embed
transit
metal
cation
pom
base
recent
discov
ln
w
cluster
largest
polyoxotungst
type
among
present
select
compound
gener
interest
incorpor
lanthanoid
cation
pom
promis
respect
potenti
doubl
function
diagnost
eg
luminesc
mri
therapeut
agent
pom
preyssler
type
bear
resembl
dawson
type
due
arrang
five
pw
unit
dawsonrel
surfac
pom
lindqvist
type
compact
smallest
structur
type
round
classic
pom
spectrum
pom
character
ir
spectroscopi
analyt
method
requir
eg
nmr
singl
crystal
structur
determin
stabl
appli
experiment
condit
proteas
express
escherichia
coli
plyss
cell
purifi
anion
exchang
size
exclus
chromatographi
accord
literatur
protocol
experiment
detail
cf
supplementari
data
given
proteas
autocatalyt
activ
site
well
autoprotolyt
activ
special
attent
must
paid
high
puriti
protein
precis
determin
concentr
prevent
possibl
interact
pom
degrad
proteas
fragment
proteas
assay
reason
substitut
one
singl
amino
acid
name
glutamin
posit
lysin
perform
reach
increas
protein
stabil
residu
locat
first
loop
first
bstrand
protein
consider
spatial
distanc
flexibl
hing
region
propos
pom
bind
site
therefor
practic
exclud
use
mutant
affect
inhibitori
potenti
pom
comparison
wild
type
introduct
posit
charg
lysin
might
even
exert
product
elec
trostat
effect
upon
bind
highli
neg
charg
pom
proteas
standard
proteas
assay
perform
describ
supplementari
data
influenc
pom
absorb
measur
exclud
proteas
substrat
dissolv
dimethyl
sulfoxid
dmso
two
differ
buffer
solut
appli
buffer
contain
final
dmso
concentr
wherea
dmso
content
buffer
detail
cf
supplementari
data
stabil
proteas
assay
confirm
selwyn
test
known
standard
enzymat
stabil
test
till
date
buffer
condit
inhibitori
potenti
pom
analyz
triplic
measur
saquinavir
standard
inhibitor
buffer
condit
furthermor
ingredi
two
differ
buffer
compar
condit
use
pom
known
high
inhibitori
activ
cf
tabl
tabl
higher
concentr
dmso
addit
deterg
nonidet
obvious
exert
signific
influenc
measur
inhibit
cf
fig
although
addit
deterg
nonidet
suppos
stabil
proteas
assay
enzymat
reaction
also
work
detergentfre
buffer
lower
dmso
concentr
importantli
buffer
addit
test
show
pominduc
proteas
inhibit
mere
artefact
aris
precipit
proteas
substrat
reaction
rel
activ
proteas
buffer
shown
figur
pom
ad
excess
rel
proteas
buffer
rel
proteas
activ
remain
higher
reaction
wherea
saquinavir
appli
ratio
led
inhibit
exclud
experiment
setup
error
indic
inhibit
enzymat
reaction
pom
occur
condit
especi
pom
result
unexpect
comparison
previous
report
high
potenti
proteas
inhibit
howev
chang
condit
buffer
complet
alter
overal
activ
pattern
although
use
deterg
dmso
concentr
report
exert
stabil
effect
hiv
proteas
activ
buffer
dmso
less
ingredi
suffici
keep
proteas
activ
declin
enzymat
reaction
observ
almost
experi
line
preced
result
pom
led
total
proteas
inhibit
well
pom
detail
discuss
result
obtain
buffer
pom
classifi
watersolubl
pom
function
dmsosolubl
pom
organ
side
chain
interestingli
previou
studi
point
dmso
influenc
enzymat
reaction
rather
complex
manner
vari
widelyfrom
stimul
inhibitori
effectsfor
differ
system
investig
howev
appli
pristin
proteas
present
case
dmso
depend
pominduc
proteas
inhibit
contrast
gener
inhibit
saquinavir
point
differ
interact
mechan
organ
inorgan
inhibitor
suggest
earlier
studi
comparison
watersolubl
pom
signific
inhibitori
potenti
indic
pom
relat
dawson
type
gener
superior
remain
pom
architectur
investig
studi
pom
concern
pom
larger
cluster
size
promot
proteas
inhibit
likewis
dimer
structur
pom
bring
forward
signific
inhibitori
activitynor
smaller
h
w
anion
pom
perform
even
slightli
wors
keggin
compound
relat
size
pom
result
render
dawson
type
especi
promis
construct
function
antivir
pom
provid
abovement
buffer
influenc
taken
account
dimens
dawson
cluster
inde
appear
appropri
rang
pomprotein
interact
indic
preced
theoret
studi
detail
comparison
inhibitori
effect
among
dmsosolubl
pom
found
figur
pom
keggin
type
deriv
wherea
pom
dawson
type
pom
function
organ
side
chain
pom
posit
pom
respect
first
glanc
figur
show
distinct
keggin
dawson
type
pom
even
introduct
organ
residu
keggin
type
pom
butyl
side
chain
induc
complet
inhibit
proteas
activ
fig
gener
introduct
butyl
side
chain
exert
strongest
inhibitori
effect
among
dmsosolubl
pom
regardless
pom
framework
dawson
regiosom
effect
even
maintain
excess
butylsubstitut
pom
case
propion
acid
residu
keggin
type
deriv
well
compet
dawson
analog
term
inhibitori
effect
fig
parallel
attach
figur
rel
activ
proteas
presenc
differ
pom
potenti
inhibitor
cf
tabl
reaction
perform
buffer
buffer
respect
total
reaction
volum
pom
ad
concentr
lm
nm
asterisk
activ
proteas
reaction
without
pom
defin
saq
saquinavir
ment
complex
peptidebas
side
chain
significantli
reduc
proteas
activ
irrespect
pom
host
structur
keggin
dawson
type
cf
fig
although
result
interpret
caution
due
limit
number
pom
involv
present
studi
comparison
manifold
experiment
variabl
buffer
composit
pom
concentr
entireti
indic
function
pom
organ
moieti
exert
product
effect
potenti
proteas
inhibit
dawson
type
pom
display
promis
overal
inhibitori
perform
present
studi
seem
gener
high
antivir
potenti
classic
type
difficult
obtain
mani
newli
discov
larger
polyoxotungst
investig
ln
w
type
context
recent
luminesc
studi
interact
eu
w
tb
w
humanbovin
serum
albumin
also
show
protein
bind
mode
differ
consider
smaller
decatungst
cluster
thu
point
pom
size
import
factor
structureact
relationship
howev
introduct
organ
side
chain
may
import
tool
modifi
structur
activ
relationship
among
differ
pom
cluster
type
order
amplifi
antivir
potenti
pom
gener
support
fact
introduct
butyl
group
keggin
type
pom
drastic
improv
inhibitori
perform
comparison
pristin
keggin
pom
amphiphil
pom
unpolar
organ
substitu
turn
perform
quit
well
proteas
inhibit
reason
inhibitori
potenti
pristin
organ
compound
might
also
test
refer
howev
result
also
rais
critic
point
taken
account
futur
studi
base
present
buffer
addit
test
interact
pom
substrat
complet
exclud
order
detect
possibl
interact
peptid
substrat
pom
use
solut
nmr
techniqu
particular
chemic
shift
map
mhz
proton
spectra
record
approx
lm
peptid
solut
ph
mm
acet
buffer
absenc
presenc
pom
display
signific
proteas
inhibit
two
sampl
prepar
peptid
stock
solut
one
pom
ad
ph
care
control
differ
less
ph
unit
two
sampl
region
aliphat
proton
display
littl
differ
wherea
amid
proton
experienc
small
shift
chang
nevertheless
observ
differ
spectra
minor
fig
chang
estim
k
like
molar
rang
strongli
disfavor
specif
interact
reason
affin
indic
presenc
lowaffin
nonspecif
interact
conclud
data
lowaffin
nonspecif
interact
pom
peptid
occur
strength
weak
reason
observ
inhibit
substrat
cleavag
proteas
ultim
proof
pomproteas
interact
would
certainli
crystal
pomprotein
complex
challeng
goal
never
reach
sever
decad
antihiv
studi
pom
anoth
option
would
pulldown
experi
pom
link
bead
incub
proteas
substrat
respect
follow
wash
step
analysi
residu
howev
would
studi
right
pombead
link
method
would
develop
altern
proteas
would
stabil
coupl
summari
present
screen
studi
outlin
sever
methodolog
issu
screen
pom
proteas
activ
consid
followup
experi
name
composit
buffer
system
exclus
pomsubstr
interact
optim
studi
howev
worthwhil
demonstr
function
dawson
keggin
type
pom
organ
moieti
like
enhanc
inhibitori
potenti
amplifi
rang
antivir
pom
type
thu
render
biocompat
studi
concern
cytotox
cellular
uptak
antivir
pom
way
dr
firasat
hussain
experiment
help
regard
pom
synthesi
prof
dr
oliv
zerb
institut
organ
chemistri
univers
zurich
support
nmr
studi
furthermor
grate
dr
jovan
pavlov
institut
medic
virolog
univers
zurich
switzerland
provid
templat
plasmid
contain
wild
type
genom
saquinavir
obtain
aid
research
refer
reagent
program
divis
aid
niaid
nih
supplementari
data
express
purif
proteas
synthesi
inhibitor
screen
pom
well
addit
screen
test
compar
differ
buffer
associ
articl
found
onlin
version
